IL10 and type 2 diabetes mellitus: IL-10 production and IL-4 response (reported as anti-osteoclastogenic cytokines) were promoted and IL-7 response (reported as osteoclastogenic cytokines)26 was inhibited, indicating that osteoimmune system may regulate bone metabolism through an osteoclast inhibition microenvironment in T2D mice.